Clinical Trial: An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869264) titled 'An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan' on Oct. 06.

Brief Summary: The primary purpose of this study is to describe the incidence and severity of known adverse events, including amyloid-related imaging abnormalities (ARIA)-oedema/effusion (ARIA-E), ARIA-microhemorrhage and haemosiderin deposit (ARIA-H), intracerebral hemorrhage greater than 1 cm, and anaphylaxis (stratified by apolipoprotein E4 variant [APOE4] genotype, concomitant antithrombotic therapy, and comorbid cerebral amyloid angiopathy [CAA]), in participants treated with LEQEMBI in routine clinical practice in Taiwan.

To describe previou...